Education
About Us
Working with TipRanks
Follow Us
Idexx Laboratories (IDXX)
NASDAQ:IDXX
Total Valuation
Idexx Laboratories has a market cap or net worth of $51.07B. The enterprise value is $50.41B.
Market Cap$51.07B
Enterprise Value$50.41B
Share Statistics
Idexx Laboratories has 79,851,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding79,851,330
Owned by Insiders0.28%
Owned by Institutions1.59%
Financial Efficiency
Idexx Laboratories’s return on equity (ROE) is 0.66 and return on invested capital (ROIC) is 40.68%.
Return on Equity (ROE)0.66
Return on Assets (ROA)0.32
Return on Invested Capital (ROIC)40.68%
Return on Capital Employed (ROCE)0.62
Revenue Per Employee391.25K
Profits Per Employee96.31K
Employee Count11,000
Asset Turnover1.28
Inventory Turnover4.35
Valuation Ratios
The current PE Ratio of Idexx Laboratories is 48.4. Idexx Laboratories’s PEG ratio is 2.30.
PE Ratio48.4
PS Ratio12.59
PB Ratio33.75
Price to Fair Value33.75
Price to FCF51.26
Price to Operating Cash Flow42.87
PEG Ratio2.30
Income Statement
In the last 12 months, Idexx Laboratories had revenue of 4.30B and earned 1.06B in profits. Earnings per share was 13.17.
Revenue4.30B
Gross Profit2.66B
Operating Income1.36B
Pretax Income1.32B
Net Income1.06B
EBITDA1.47B
Earnings Per Share (EPS)13.17
Cash Flow
In the last 12 months, operating cash flow was 1.18B and capital expenditures -124.68M, giving a free cash flow of 1.06B billion.
Operating Cash Flow1.18B
Free Cash Flow1.06B
Free Cash Flow per Share13.24
Dividends & Yields
Idexx Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.93
52-Week Price Change35.00%
50-Day Moving Average702.38
200-Day Moving Average612.76
Relative Strength Index (RSI)26.65
Average Volume (3m)396.18K
Important Dates
Idexx Laboratories upcoming earnings date is May 6, 2026, Before Open (Confirmed).
Last Earnings DateFeb 2, 2026
Next Earnings DateMay 6, 2026
Ex-Dividend Date―
Financial Position
Idexx Laboratories as a current ratio of 1.23, with Debt / Equity ratio of 4.67%
Current Ratio1.23
Quick Ratio0.90
Debt to Market Cap0.02
Net Debt to EBITDA-0.07
Interest Coverage Ratio35.54
Taxes
In the past 12 months, Idexx Laboratories has paid 264.73M in taxes.
Income Tax264.73M
Effective Tax Rate0.20
Enterprise Valuation
Idexx Laboratories EV to EBITDA ratio is 36.82, with an EV/FCF ratio of 51.16.
EV to Sales12.57
EV to EBITDA36.82
EV to Free Cash Flow51.16
EV to Operating Cash Flow45.76
Balance Sheet
Idexx Laboratories has $180.07M in cash and marketable securities with $75.00M in debt, giving a net cash position of $105.08M billion.
Cash & Marketable Securities$180.07M
Total Debt$75.00M
Net Cash$105.08M
Net Cash Per Share$1.32
Tangible Book Value Per Share$20.04
Margins
Gross margin is 61.80%, with operating margin of 31.60%, and net profit margin of 24.62%.
Gross Margin61.80%
Operating Margin31.60%
Pretax Margin30.77%
Net Profit Margin24.62%
EBITDA Margin34.13%
EBIT Margin31.66%
Analyst Forecast
The average price target for Idexx Laboratories is $789.29, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$789.29
Price Target Upside23.40% Upside
Analyst ConsensusModerate Buy
Analyst Count8
Revenue Growth Forecast8.39%
EPS Growth Forecast21.44%